Expenditure for oncology drugs in Italy 2022, by category
Over the course of 2022, the total expenditure for oncology drugs in Italy amounted to almost 4.4 billion euros. This statistic breaks down this figure by category. According to the data, the spending on monoclonal antibodies amounted to approximately 1.8 billion euros, whereas the expenditure for tyrosine kinase inhibitors reached almost 1.2 billion euros. These two categories were by far the two oncology drugs on which the most money was spent.
